The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...

When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...

Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations ...

A nationwide Finnish study shows that children with ADHD stay on medication for over three years on average. Yet, controlled ...

The FDA now requires updated labeling for all extended-release stimulant medications used to treat attention deficit hyperactivity disorder, warning of increased risk of weight loss and other side ...

Telehealth prescribing of stimulants for teens and adults with ADHD is not linked to a higher risk for substance use disorder vs in-person prescribing, a new study shows.

The U.S. Food and Drug Administration said on Monday that it is revising the labeling of all extended-release stimulants to ...

The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit ...

Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants.